About Roivant Sciences Ltd. 
Roivant Sciences Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 76 Schemes (29.04%)
Foreign Institutions
Held by 157 Foreign Institutions (17.16%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Jun 2025)
Net Profit:
-274 Million
Pharmaceuticals & Biotechnology
USD 8,816 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.03
-23.18%
2.03






